Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039884
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2002-06-13
Brief Title:
Will RadiationChemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia
Sponsor:
Mirhashemi Ramin MD
Organization:
Mirhashemi Ramin MD
Study Overview
Official Title:
Phase II Study of NESP Novel Erythropoiesis Stimulating Protein During Concurrent Chemo-Radiation for the Treatment of Cervical Carcinoma
Status:
UNKNOWN
Status Verified Date:
2002-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a clinical trial a type of research study designed to describe the efficacy effectiveness and toxicity safety of a new medical treatment NESP Novel Erythropoiesis Stimulating Protein This study will be offered to patients with cervical cancer undergoing a combination of chemotherapy and radiation This treatment may lower your red blood cells The use of NESP may stimulate the body to produce more red blood cells Our hypothesis is that higher red blood cells will be beneficial to the patient during treatment for cervical cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None